Core Viewpoint - Beihai Kangcheng-B (01228) experienced a decline of over 10%, with a current price of 1.87 HKD and a trading volume of 42.33 million HKD [1] Summary by Relevant Sections Company Announcement - Beihai Kangcheng-B announced a subscription agreement with Baiyang Health Industry International Trade Co., Ltd. to issue 74.9715 million subscription shares at a price of 1.34 HKD per share [1] - The subscription price of 1.34 HKD represents a discount of approximately 19.76% compared to the closing price of 1.67 HKD on August 11, 2025 [1] Financial Implications - The total proceeds from the subscription will amount to 100 million HKD, with a net estimated amount of approximately 98.6618 million HKD after deducting related expenses [1] - The net proceeds are intended for the development of commercialized products, marketing and promotional activities, repayment of loan financing, and daily operations of the group [1]
港股异动 北海康成-B(01228)回落逾10% 近日拟折让约19.76%向百洋医药发行7497.15万股认购股份